Veracyte Target Price

Where could VCYT trade next? Consensus target price: $57.

Get informed when a big investor buys or sells

+ Follow

Share Price

$39.8

Average Target Price

$57.45

44.4% upside

11 analysts in the last 4 months

High: $69 | Low: $44

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-09	UBS	$65	63.3% upside
2026-08-04	Morgan Stanley	$44	10.6% upside
2026-08-04	Stephens	$55	38.2% upside
2026-08-04	Piper Sandler	$54	35.7% upside
2026-08-03	Canaccord GenuityKyle Mikson	$50	25.6% upside
2026-07-31	NeedhamMike Matson	$69	73.4% upside
2026-07-15	Piper SandlerDavid Westenberg	$66	65.8% upside
2026-07-14	Canaccord Genuity	$60	50.8% upside
2026-07-09	Morgan Stanley	$47	18.1% upside
2026-06-29	GuggenheimSubbu Nambi	$65	63.3% upside
2026-06-01	NeedhamMike Matson	$57	43.2% upside
2026-05-06	UBS	$52	30.7% upside
2026-05-06	Canaccord GenuityKyle Mikson	$42	5.5% upside
2026-03-05	Morgan StanleyKallum Titchmarsh	$37	7% downside
2026-01-05	GuggenheimSubbu Nambi	$50	25.6% upside
2025-12-01	Morgan Stanley	$48	20.6% upside
2025-11-05	UBSLu Li	$48	20.6% upside
2025-11-05	Canaccord GenuityKyle Mikson	$43	8.1% upside
2025-10-20	Canaccord GenuityKyle Mikson	$40	0.5% upside
2025-08-08	Morgan StanleyTejas Savant	$28	29.6% downside
2024-11-07	NeedhamMike Matson	$44	10.6% upside
2024-08-12	Morgan StanleyTejas Savant	$26	34.7% downside
2022-05-04	Morgan Stanley	$23	42.2% downside
2022-05-04	Needham	$26	34.7% downside

Veracyte (VCYT) FAQ

The latest target price for VCYT is $57. Investors often review this figure alongside Veracyte's historical trend and sector peers before judging valuation or financial health.

Veracyte trades near $39.8 while the consensus target sits at $57 (44.4% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting VCYT's target price ($57), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Veracyte's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.